Reactivelor, calibratoarelor, controalelor si consumabilelor pentru analizatorul ARHITECT CI 16200, Reagenti p/u Immulite 2000 XPI (sistem inchis), Reagenţi p/u analizatorul hematologic XT-2000i f.
Information about customer
Title
IMSP CRDM
IDNO
1003600150196
Address
MOLDOVA,
locality,
str. C. Virnav 13,
2025
The contact person
Cuznetov Tatiana,
cuznetovtaticrdm@gmail.com
Purchase data
ID
ocds-b3wdp1-MD-1663047444866
Title
Reactivelor, calibratoarelor, controalelor si consumabilelor pentru analizatorul ARHITECT CI 16200, Reagenti p/u Immulite 2000 XPI (sistem inchis), Reagenţi p/u analizatorul hematologic XT-2000i f.
Note
CPV Code
33600000-6 - Produse farmaceutice
Rationale
List of funding sources
Funding source cost
3256000.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1663047444866-FS-1663049587643
IBAN
None
Funding source cost
3256000.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1663047444866-FS-1663047445704
IBAN
None
Funding source cost
3256000.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1663047444866-FS-1667813676863
IBAN
None
Funding source cost
3256000.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1663047444866-FS-1667813676783
IBAN
None
Funding source cost
3256000.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1663047444866-FS-1668163250390
IBAN
None
Funding source cost
3256000.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1663047444866-FS-1668163250057
IBAN
None
Funding source cost
3256000.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1663047444866-FS-1668163250567
IBAN
None
Funding source cost
3256000.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1663047444866-FS-1668163250222
IBAN
None
Funding source cost
3256000.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1663047444866-FS-1670335766529
IBAN
None
Funding source cost
3256000.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1663047444866-FS-1670335765294
IBAN
None
Funding source cost
3256000.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1663047444866-FS-1670335765980
IBAN
None
Funding source cost
3256000.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1663047444866-FS-1670335765784
IBAN
None
Funding source cost
3256000.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1663047444866-FS-1670335765432
IBAN
None
Funding source cost
3256000.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1663047444866-FS-1670335766178
IBAN
None
Funding source cost
3256000.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1663047444866-FS-1670335765584
IBAN
None
Funding source cost
3256000.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1663047444866-FS-1670335766336
IBAN
None
Funding source cost
3256000.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1663047444866-FS-1670480732052
IBAN
None
Funding source cost
3256000.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1663047444866-FS-1670480732252
IBAN
None
Funding source cost
3256000.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1663047444866-FS-1670480732882
IBAN
None
Funding source cost
3256000.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1663047444866-FS-1670480732487
IBAN
None
Funding source cost
3256000.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1663047444866-FS-1670480733621
IBAN
None
Funding source cost
3256000.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1663047444866-FS-1670480733189
IBAN
None
Funding source cost
3256000.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1663047444866-FS-1670480732694
IBAN
None
Funding source cost
3256000.0 MDL
Funding source period
From 1 Jan 2022 to 1 Jan 2023
Funding source ID
ocds-b3wdp1-MD-1663047444866-FS-1670480733389
IBAN
None
Status Planning
Start the procedure:
1 Jan 2022
1 Jan 2023
Date of publication: 13 Sep 2022 08:37
Date of last modifications: 20 Dec 2022 18:35